TwinBeech Capital’s Novavax NVAX Stock Holding History

TwinBeech Capital’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-30,076	Closed	-$245K	–	589
2026 Q1	$245K	Buy	+30,076	New	+$273K	0.03%	483
2025 Q1	–	Sell	-69,034	Closed	-$555K	–	884
2024 Q4	$555K	Buy	+69,034	New	+$666K	0.01%	443
2023 Q2	–	Sell	-28,499	Closed	-$197K	–	779
2023 Q1	$197K	Buy	+28,499	New	+$262K	﹤0.01%	564
2022 Q3	–	Sell	-30,907	Closed	-$1.59M	–	751
2022 Q2	$1.59M	Buy	+30,907	New	+$1.6M	0.07%	252
2022 Q1	–	Sell	-23,703	Closed	-$3.39M	–	677
2021 Q4	$3.39M	Buy	+23,703	New	+$4.07M	0.19%	151
2021 Q2	–	Sell	-7,280	Closed	-$1.32M	–	589
2021 Q1	$1.32M	Buy	+7,280	New	+$1.45M	0.19%	161

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

TwinBeech Capital's NVAX Position: Q2 2026 in Review

TwinBeech Capital sold out of Novavax (NVAX) in Q2 2026, closing a stake of 30,076 shares — an estimated $245K sold.

TwinBeech Capital first reported a position in NVAX in Q1 2021 and held it in 6 quarters. The position peaked at $3.39M in Q4 2021. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

TwinBeech Capital reported no remaining Novavax position as of Q2 2026 after selling out during the quarter.
TwinBeech Capital sold 30,076 Novavax shares in Q2 2026, an estimated $245K.
TwinBeech Capital first reported a position in Novavax in Q1 2021 and held it in 6 quarters.
TwinBeech Capital's Novavax position peaked at $3.39M in Q4 2021.
266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.